Suzanne Oparil Selected Research

Suzanne Oparil Research Topics

Disease

181	Hypertension (High Blood Pressure) 12/2022 - 01/2002
48	Myocardial Infarction 11/2021 - 03/2002
33	Stroke (Strokes) 12/2021 - 03/2002
32	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 03/2002
26	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 03/2002
19	Heart Failure 01/2022 - 04/2008
17	Hypoxia (Hypoxemia) 05/2012 - 02/2002
16	Inflammation (Inflammations) 01/2019 - 10/2003
14	Vascular Remodeling 07/2014 - 02/2002
13	Chronic Renal Insufficiency 12/2021 - 05/2003
11	Obesity 11/2022 - 01/2010
11	Neointima 01/2017 - 08/2002
9	Hypertrophy 01/2019 - 05/2003
8	Isolated Systolic Hypertension 12/2022 - 09/2002
8	Diabetes Mellitus 01/2018 - 09/2002
8	Obstructive Sleep Apnea 09/2017 - 03/2009
8	Vascular System Injuries 01/2017 - 01/2004
7	Hyperaldosteronism (Conn Syndrome) 01/2022 - 10/2007
7	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2003
7	Cardiomegaly (Heart Hypertrophy) 12/2013 - 05/2003
5	Weight Loss (Weight Reduction) 01/2020 - 03/2009
5	Pulmonary Hypertension 12/2011 - 12/2002
4	Neoplasms (Cancer) 08/2022 - 10/2010
4	Hypotension (Low Blood Pressure) 01/2021 - 11/2015
4	Prehypertension 01/2021 - 04/2006
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 11/2015
4	Syncope (Fainting) 01/2021 - 11/2015
4	Albuminuria 01/2019 - 09/2004
4	Chronic Kidney Failure (Chronic Renal Failure) 03/2015 - 05/2009
4	Insulin Resistance 12/2013 - 11/2005
4	Fibrosis (Cirrhosis) 09/2011 - 11/2004
4	Essential Hypertension 01/2008 - 08/2003
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 11/2005
3	Infarction (Infarctions) 01/2018 - 02/2012
3	Vascular Diseases (Vascular Disease) 07/2013 - 08/2003

Drug/Important Bio-Agent (IBA)

110	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 03/2002
32	LipidsIBA 11/2022 - 05/2003
28	DiureticsIBA 01/2022 - 03/2002
27	Amlodipine (Norvasc)FDA LinkGeneric 01/2021 - 09/2006
25	Losartan (Cozaar)FDA LinkGeneric 03/2009 - 03/2002
21	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2021 - 09/2006
21	Atenolol (Tenormin)FDA LinkGeneric 11/2013 - 03/2002
19	AldosteroneIBA 01/2021 - 04/2003
17	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2003
17	Pharmaceutical PreparationsIBA 12/2020 - 01/2002
16	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2020 - 01/2005
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 05/2003
15	SodiumIBA 01/2022 - 06/2006
15	Lisinopril (Prinivil)FDA LinkGeneric 01/2021 - 09/2006
14	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 05/2003
13	Olmesartan Medoxomil (Votum)FDA Link 01/2020 - 03/2007
13	Atrial Natriuretic Factor (ANF)IBA 10/2011 - 02/2002
11	ReninIBA 01/2017 - 07/2007
10	ThiazidesIBA 11/2020 - 05/2003
10	SaltsIBA 01/2020 - 02/2002
10	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2003
10	Estrogens (Estrogen)FDA Link 07/2015 - 10/2003
9	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 03/2009
9	Messenger RNA (mRNA)IBA 07/2011 - 08/2003
8	Dietary SodiumIBA 01/2020 - 06/2006
8	Valsartan (Vals)FDA Link 01/2017 - 01/2005
8	CollagenIBA 08/2013 - 07/2003
8	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2012 - 02/2006
7	aliskiren FDA Link 02/2013 - 07/2007
6	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2022 - 12/2003
6	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 03/2008
6	olmesartanIBA 01/2018 - 01/2008
6	Renin InhibitorsIBA 10/2012 - 09/2007
6	Transforming Growth Factor beta (TGF-beta)IBA 02/2010 - 02/2006
5	PotassiumIBA 10/2018 - 03/2008
5	CytokinesIBA 01/2018 - 10/2003
5	Interleukin-8 ReceptorsIBA 01/2017 - 03/2012
5	salicylhydroxamic acid (SHAM)IBA 05/2016 - 09/2006
5	Valsartan Drug Combination Amlodipine FDA Link 01/2014 - 12/2009
5	C-Reactive ProteinIBA 01/2014 - 10/2003
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 07/2003
5	Endothelin A ReceptorIBA 05/2012 - 12/2002
5	Angiotensin IIIBA 01/2009 - 08/2003
5	N-propionylprocainamideIBA 09/2006 - 05/2003
4	ElectrolytesIBA 01/2021 - 11/2015
4	CreatinineIBA 01/2019 - 09/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2009
4	Endothelin-1 (Endothelin 1)IBA 01/2017 - 01/2007
4	BQ 610IBA 05/2012 - 12/2002
4	PeriostinIBA 10/2006 - 07/2003
4	OsteopontinIBA 08/2006 - 08/2002
3	Doxazosin (Cardura)FDA LinkGeneric 01/2021 - 09/2006
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 09/2005
3	Neprilysin (Neutral Endopeptidase)IBA 01/2019 - 12/2012
3	Interleukin-8 (Interleukin 8)IBA 07/2014 - 03/2012
3	AlbuminsIBA 09/2013 - 09/2004
3	Hormones (Hormone)IBA 07/2013 - 10/2003
3	Neutralizing AntibodiesIBA 05/2012 - 07/2011

Therapy/Procedure

56	Therapeutics 11/2022 - 08/2002
11	Denervation 12/2017 - 02/2012
6	Bariatric Surgery 01/2020 - 02/2017
6	Drug Therapy (Chemotherapy) 05/2017 - 11/2005
4	Catheters 04/2015 - 02/2012
3	Ambulatory Care (Outpatient Care) 01/2021 - 01/2019
3	Secondary Prevention 10/2016 - 01/2003